Insulin Aspart vs GLP-1

Head-to-head comparison of Insulin Aspart (Insulin aspart (B28-Asp human insulin analog)) and GLP-1 (Glucagon-like peptide-1 (7-36 amide)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyInsulin AspartGLP-1
CategoryDiabetes & MetabolicDiabetes & Metabolic
Full NameInsulin aspart (B28-Asp human insulin analog)Glucagon-like peptide-1 (7-36 amide)
Molecular Weight5825.8 Da3297 Da
Half-LifeAbout 1-3 hours1-2 minutes
Amino Acids5130
Typical Dose0.05-0.2 U/kg per mealResearch-only: 0.1-1.0 pmol/kg/min
RouteSubcutaneousIntravenous/Subcutaneous
Purity≥98%≥98%
Studies Count110001200
Research StatusApprovedPre-clinical

Insulin Aspart Benefits

  • Fast post-meal glucose lowering
  • Predictable onset
  • Flexible mealtime administration
  • Compatible with pump therapy

GLP-1 Benefits

  • beta-cell protection
  • improved insulin secretion
  • slower gastric emptying
  • lower postprandial glucose

Insulin Aspart Dosing

Inject SC immediately before meals|Titrate using glucose monitoring and carbohydrate intake|Can be used in insulin pumps or basal-bolus regimens

GLP-1 Dosing

0.1-1.0 pmol/kg/min IV infusion in research|0.5-10 nM in vitro|continuous delivery in animal studies

Insulin Aspart Side Effects

  • Hypoglycemia
  • Injection-site reactions
  • Weight gain

GLP-1 Side Effects

  • nausea at pharmacologic exposure
  • tachyphylaxis with continuous exposure
  • headache

Research Overview

Insulin Aspart

Research consistently shows faster onset and earlier peak action than regular human insulin. It is commonly studied for meal-time glycemic control and pump-based insulin delivery.

GLP-1

Native GLP-1 has a very short half-life because of rapid DPP-4 cleavage, so it is mainly used as a mechanistic research peptide. Across animal and cellular studies it reduces beta-cell apoptosis, improves insulin gene expression, and enhances islet resilience.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Insulin Aspart stacks with:

Insulin GlargineInsulin Degludec

GLP-1 stacks with:

DPP-4 inhibitorsSGLT2 inhibitorsdiet and exercise
rapid-acting insulinmeal coveragepump-compatibleincretinbeta-cell survivalDPP-4 substrate